GlassScriptPhysician profile
Dawn T Van
NPI 1689684466
$1,496.18
in general payments reported to CMS, 2019-2025
11 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.21 · 2020: $116 · 2021: $254 · 2022: $194 · 2023: $110 · 2024: $368 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683 · Entertainment: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.46 |
| Entertainment | $195.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $663.96 | 2021-2025 | Acuvue |
| Coopervision INC. | $270.19 | 2019-2024 | Myday Contact Lens |
| Optos, INC. | $195.96 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $157.80 | 2024-2025 | Precision7, Total30 |
| Topcon Healthcare, INC. | $71.09 | 2020 | |
| Bausch & Lomb Americas INC. | $40.05 | 2024-2025 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $27.80 | 2024 | Xdemvy |
| Allergan, INC. | $21.86 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.41 | 2020 | |
| Abb Con-Cise Optical Group LLC | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.